» Articles » PMID: 11383585

Inflammatory Bowel Disease-like Colitis in Glycogen Storage Disease Type 1b

Overview
Specialty Gastroenterology
Date 2001 Jun 1
PMID 11383585
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammatory bowel disease (IBD)-like colitis is occasionally associated with glycogen storage disease-type 1b (GSD-1b). We describe a 17-year old boy with GSD-1b who developed an IBD-like colitis. Roentgenography and colonoscopy showed the lead-pipe appearance of the colon and circumferential ulcers. Histopathologic examination revealed nonspecific inflammation without granulomatous lesions. High-dose granulocyte-colony stimulating factor (G-CSF) and sulfasalazine led to the resolution of the colitis, although neutropenia continued. Besides this case, 10 published cases of GSD-1b and IBD-like colitis were reviewed. All cases had severe neutropenia and/or neutrophil dysfunction. The mean onset of bowel disease was 12.3 years of age. Seven cases required surgical treatment. All five patients with G-CSF/GM-CSF therapy showed clinical remission. These findings suggest that IBD-like colitis is a grave complication of GSD-1b and that recurrent enteric infections due to neutrophil deficiency may contribute to the development of this bowel disease.

Citing Articles

Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China.

Zhang X, Su Z, Wu J, Zeng H, Jiang X, Wang Y Orphanet J Rare Dis. 2025; 20(1):41.

PMID: 39875987 PMC: 11773708. DOI: 10.1186/s13023-025-03570-1.


SLC37A4, gene responsible for glycogen storage disease type 1b, regulates gingival epithelial barrier function via JAM1 expression.

Tanigaki K, Matsumura R, Sasaki N, Kato Y, Tamamori T, Yamaga S Sci Rep. 2024; 14(1):24797.

PMID: 39433915 PMC: 11494063. DOI: 10.1038/s41598-024-75524-9.


Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial.

Li Z, Zhang X, Chen H, Zeng H, Wu J, Wang Y Sci Rep. 2024; 14(1):8630.

PMID: 38622211 PMC: 11018849. DOI: 10.1038/s41598-024-59320-z.


Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity.

Hall C, de Zoeten E Immunol Rev. 2023; 322(1):329-338.

PMID: 38115672 PMC: 11044353. DOI: 10.1111/imr.13302.


Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review.

Wang Z, Zhao R, Jia X, Li X, Ma L, Fu H J Int Med Res. 2023; 51(12):3000605231216633.

PMID: 38087503 PMC: 10718061. DOI: 10.1177/03000605231216633.